Nutriband Inc. (NASDAQ:NTRB – Free Report) – Noble Financial dropped their Q2 2026 EPS estimates for Nutriband in a report released on Monday, June 2nd. Noble Financial analyst R. Leboyer now forecas… [+2386 chars]...
Read moreShares of Nutriband Inc. (NASDAQ:NTRB – Get Free Report) rose 1.7% during mid-day trading on Thursday . The company traded as high as $7.86 and last traded at $7.83. Approximately 21,051 shares chang… [+2346 chars]...
Read moreNutriband and Kindeva have completed commercial manufacturing process scale-up for its lead product Aversa Fentanyl, an abuse-deterrent fentanyl patch Nutriband is partnering with Kindeva to develop… [+6984 chars]...
Read moreORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), has been added as a member of the Russell Microcap, Russell Microcap Growth, Russell 3000E and Russell 30… [+6478 chars]...
Read morePatent issuance expands United States patent coverage for AVERSA transdermal abuse deterrent technology AVERSA transdermal abuse deterrent technology is protected by a broad international intellectu… [+4880 chars]...
Read morePALM BEACH, Fla., June 18, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The market for abuse-deterrent opioids is still developing, but it's estimated that replacing extended-release opi… [+15495 chars]...
Read more